US snaps up first supplies of Regeneron’s COVID-19 antibody
GenMark Soaring In Pre-Market On 118% Revenue Explosion
Trump and Navarro press again for hydroxychloroquine. Can the FDA stay independent?
Chembio Gains 12% After-Hours On New Covid-19 BARDA Contract
Gilead Licencee Gets Indian Regulatory Approval For Remdesivir Covid-19 Therapy
FDA Sets Bar for COVID-19 Vaccine Approval at 50 Percent Effectiveness
Gilead Sets Pricing For Remdesivir Vaccine At $2,340 Per Patient
Covid-19 roundup: Moderna enlists Catalent as manufacturing partner, securing fill-finish capacity for the first 100M doses
APT Doubles While Other Biotechs Take Off On Rising New Coronavirus Case Numbers
Gilead Aims To Produce More Than 2 Million Remdesivir Courses By Year-End
Coronavirus pharma news roundup – 19/06/20
US left with huge hydroxychloroquine stockpile after COVID-19 trial failures
Chembio Sinks 59% In Pre-Market As FDA Revokes Its Covid-19 Test; Top Analyst Cuts Rating
Fulgent Pops 18% In After-Market On FDA Nod For Covid-19 Home Test
UK stops recruitment to hydroxychloroquine COVID-19 trials
FDA warns against combination of malaria drug and Gilead’s remdesivir
The FDA backs off a hasty — and damaging — emergency OK for a potentially dangerous Covid-19 drug
U.S. FDA revokes emergency use status of drug touted by Trump for COVID-19
FDA Withdraws Emergency Authorization For Hydroxychloroquine After HHS Official Makes Request
Dr Reddy’s Labs Signs Licensing Agreement For Gilead’s Remdesivir
Lilly CSO: COVID-19 Antibody Treatment Could Be Ready by Fall 2020
Sorrento Soars 17% In Pre-Market On Covid-19 Test Application
Lilly COVID-19 treatment could be authorized for use as soon as September
After Novavax Inks DoD Contract, Is Operation Warp Speed Ahead? Top Analyst Weighs In
Idexx Unit Gets European Union Regulatory Nod For Covid-19 Test Kit
Novavax Surging On $60M Funding For Covid-19 Vaccine Candidate
Estimating a US price tag of $5K per course, remdesivir is set to make billions for Gilead, says key analyst
Quest Sees Q2 EPS In Range Of Breakeven To Profitable On Testing Volume Recovery
Philips Gets FDA Emergency Use Nod For Monitors, Displays During Covid-19 Pandemic
Can antibody tests tell us who is immune to COVID-19?